国际标准期刊号: 2329-6879

职业医学与健康事务

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 打开 J 门
  • 学术钥匙
  • 中国知网(CNKI)
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • 日内瓦医学教育与研究基金会
  • ICMJE
分享此页面

抽象的

Theranostics Nanoparticles: Revolutionizing Cancer and Imaging

Nouran Hamza

This literature review attempted to describe theranostic nanoparticles and their use in the treatment and diagnosis of cancer. Furthermore, this paper addressed nanoparticles and their potential ability to lower radioactive dose and improvement of quality in computed tomography examinations. This review also attempted to show the positive and negative effects implementing these nanoparticles have had within the modern healthcare system. Eighteen scholarly sources were selected and explored to acquire the relevant information for this review. Nanoparticles are an emerging technological trend being explored by many researchers and healthcare workers today. These technologies are revolutionizing the healthcare industry [1]. Newer prototypes and developments of nanotechnology is being introduced, created, and analyzed every day. There has been documenting about positive aspects of implementing nanoparticles into cancer treatment; their implementation as an aid to CT dose reduction and improved image quality is also to be noted. In contrast, there are many critics still opposed to the idea of utilizing this technology and view it as nothing more than a fantasy and/or novelty. Studies of the effects these technologies have on the healthcare industry, in particular cancer, show this technology has the potential to completely revolutionize the health care world. When analyzing all these factors, it would appear this technology is being adopted more frequently than ever before. Fear of change, negative perceptions, lack of specific work, cost, toxicity, and synthesis did not accurately satisfy this claim.